Novel treatment strengthens bones in genetic disease neurofibromatosis type-1




An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, investigators have discovered. The researchers demonstrated in a mouse model of the disorder that the enzyme asfotase-alpha improves bone growth, mineralization and strength.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/9...

Jueves, 14 de Agosto 2014
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección